170 related articles for article (PubMed ID: 24844800)
1. Selenium-platinum coordination compounds as novel anticancer drugs: selectively killing cancer cells via a reactive oxygen species (ROS)-mediated apoptosis route.
Zeng L; Li Y; Li T; Cao W; Yi Y; Geng W; Sun Z; Xu H
Chem Asian J; 2014 Aug; 9(8):2295-302. PubMed ID: 24844800
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine Assembled by Coordinated Selenium-Platinum Complexes Can Selectively Induce Cytotoxicity in Cancer Cells by Targeting the Glutathione Antioxidant Defense System.
Li F; Li T; Han X; Zhuang H; Nie G; Xu H
ACS Biomater Sci Eng; 2018 Jun; 4(6):1954-1962. PubMed ID: 33445265
[TBL] [Abstract][Full Text] [Related]
3. Antitumor potential of platinum(II) complexes of selenium donor ligands.
Ahmad S; Isab AA; Al-Arfaj AR
Metallomics; 2023 Apr; 15(4):. PubMed ID: 36918206
[TBL] [Abstract][Full Text] [Related]
4. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Yang YI; Kim JH; Lee KT; Choi JH
Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
[TBL] [Abstract][Full Text] [Related]
5. Treatment with a selenium-platinum compound induced T-cell acute lymphoblastic leukemia/lymphoma cells apoptosis through the mitochondrial signaling pathway.
Wu F; Cao W; Xu H; Zhu M; Wang J; Ke X
Oncol Lett; 2017 Mar; 13(3):1702-1710. PubMed ID: 28454312
[TBL] [Abstract][Full Text] [Related]
6. The reversal of cisplatin-induced nephrotoxicity by selenium nanoparticles functionalized with 11-mercapto-1-undecanol by inhibition of ROS-mediated apoptosis.
Li Y; Li X; Wong YS; Chen T; Zhang H; Liu C; Zheng W
Biomaterials; 2011 Dec; 32(34):9068-76. PubMed ID: 21864903
[TBL] [Abstract][Full Text] [Related]
7. Fast cleavage of a diselenide induced by a platinum(II)-methionine complex and its biological implications.
Liu Q; Wang X; Yang X; Liang X; Guo Z
J Inorg Biochem; 2010 Nov; 104(11):1178-84. PubMed ID: 20705343
[TBL] [Abstract][Full Text] [Related]
8. Selenium potentiates the anticancer effect of cisplatin against oxidative stress and calcium ion signaling-induced intracellular toxicity in MCF-7 breast cancer cells: involvement of the TRPV1 channel.
Sakallı Çetin E; Nazıroğlu M; Çiğ B; Övey İS; Aslan Koşar P
J Recept Signal Transduct Res; 2017 Feb; 37(1):84-93. PubMed ID: 27055401
[TBL] [Abstract][Full Text] [Related]
9. Self-assembly regulated anticancer activity of platinum coordinated selenomethionine.
Li T; Xiang W; Li F; Xu H
Biomaterials; 2018 Mar; 157():17-25. PubMed ID: 29223531
[TBL] [Abstract][Full Text] [Related]
10. Supplementation with Selenium yeast on the prooxidant-antioxidant activities and anti-tumor effects in breast tumor xenograft-bearing mice.
Guo CH; Hsia S; Hsiung DY; Chen PC
J Nutr Biochem; 2015 Dec; 26(12):1568-79. PubMed ID: 26344777
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of amino acid surface decoration on the anticancer efficacy of selenium nanoparticles.
Feng Y; Su J; Zhao Z; Zheng W; Wu H; Zhang Y; Chen T
Dalton Trans; 2014 Jan; 43(4):1854-61. PubMed ID: 24257441
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
[TBL] [Abstract][Full Text] [Related]
13. Effects of amino acids from selenium-rich silkworm pupas on human hepatoma cells.
Hu D; Liu Q; Cui H; Wang H; Han D; Xu H
Life Sci; 2005 Sep; 77(17):2098-110. PubMed ID: 15978626
[TBL] [Abstract][Full Text] [Related]
14. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and therapeutic effect of irinotecan combined with selenium nanoparticles.
Gao F; Yuan Q; Gao L; Cai P; Zhu H; Liu R; Wang Y; Wei Y; Huang G; Liang J; Gao X
Biomaterials; 2014 Oct; 35(31):8854-8866. PubMed ID: 25064805
[TBL] [Abstract][Full Text] [Related]
17. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant.
Drake EN
Med Hypotheses; 2006; 67(2):318-22. PubMed ID: 16574336
[TBL] [Abstract][Full Text] [Related]
18. Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells.
Barbanente A; Nadar RA; Esposti LD; Palazzo B; Iafisco M; van den Beucken JJJP; Leeuwenburgh SCG; Margiotta N
J Mater Chem B; 2020 Apr; 8(14):2792-2804. PubMed ID: 32159578
[TBL] [Abstract][Full Text] [Related]
19. Selenocystine induces reactive oxygen species-mediated apoptosis in human cancer cells.
Chen T; Wong YS
Biomed Pharmacother; 2009 Feb; 63(2):105-13. PubMed ID: 18511231
[TBL] [Abstract][Full Text] [Related]
20. Strategies for the development of selenium-based anticancer drugs.
Collery P
J Trace Elem Med Biol; 2018 Dec; 50():498-507. PubMed ID: 29548612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
